bulimia nervosa: A disorder characterized by recurrent episodes of binge-eating over which the individual feels a lack of control; these episodes of binge-eating are followed by recurrent compensatory behavior to prevent weight gain, usually self-induced vomiting. In addition, self-evaluation is unduly influenced by body image.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1457 |
4. Check minimum number of eventsNone |
1457 |
5. Include endpointsNone |
1457 |
6. Filter based on genotype QC (FinnGen only) |
1457 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHAVE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Bulimia nervosa (incl. atypical)
based on the number of shared cases.
Similar with more cases:
- KRA_PSY_EATING, excluding more controls
- Eating disorder
- Eating disorders
- Behavioural syndromes associated with physiological disturbances and physical factors
- Exclusions for E4_PCOS_CONSORTIUM
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9535 | 9072 | 424 |
| Only index persons | 9255 | 8860 | 395 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.26 | 0.01 |
| Only index persons | 0.31 | 0.33 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 22.20 | 21.96 | 27.11 |
| Only index persons | 22.11 | 21.91 | 26.79 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1457 | 1396 | 61 |
| Unadjusted period prevalence (%) | 0.46 | 0.48 | 0.03 |
| Median age at first event (years) | 24.28 | 24.01 | 30.50 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1319
- Matched controls
- 13188
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F50.2
ICD-10 Finland
Bulimia nervosa
4117.0
323.0
910
7
N06AB03
ATC
fluoxetine; oral
25.4
323.0
829
824
F50.9
ICD-10 Finland
Eating disorder, unspecified
384.2
323.0
420
16
F50.3
ICD-10 Finland
Atypical bulimia nervosa
2061.9
323.0
641
6
N05AH04
ATC
quetiapine; oral
7.5
217.5
647
1494
F50.0
ICD-10 Finland
Anorexia nervosa
613.0
215.7
208
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.1
192.7
581
1317
F50.8
ICD-10 Finland
Other eating disorders
243.2
186.6
188
9
F50.1
ICD-10 Finland
Atypical anorexia nervosa
503.4
180.6
176
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
8.8
163.7
391
601
N06AX16
ATC
venlafaxine; oral
6.3
161.0
517
1216
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
8.6
149.8
362
558
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
10.5
146.7
308
371
N05BA04
ATC
oxazepam; oral
4.9
139.3
591
1858
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
6.1
135.6
433
976
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.2
118.6
436
1134
P86
ICPC
Anorexia nervosa/bulimia
136.7
117.3
124
10
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
14.3
116.2
205
167
N06AB06
ATC
sertraline; oral
5.5
114.0
396
959
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
17.6
112.1
181
118
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
8.2
110.3
266
392
N03AX09
ATC
lamotrigine; oral
7.9
109.6
272
419
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.5
99.1
424
1256
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.9
98.0
241
362
N05AX12
ATC
aripiprazole; systemic
8.2
92.3
220
313
N06AX12
ATC
bupropion; oral
5.5
91.7
303
673
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.1
90.4
239
397
N06AX11
ATC
mirtazapine; oral
3.5
89.3
564
2307
N06AB10
ATC
escitalopram; oral
3.4
85.1
553
2289
N05CF01
ATC
zopiclone; oral
3.7
83.3
450
1601
N06AB04
ATC
citalopram; systemic
3.7
80.9
438
1556
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.1
80.0
192
273
N05AX08
ATC
risperidone; systemic
7.4
79.0
202
316
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
11.5
77.1
149
144
N05AH03
ATC
olanzapine; systemic
6.2
71.2
206
380
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
9.3
70.8
154
185
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
14.2
68.9
120
92
E66.8
ICD-10 Finland
Other obesity
6.0
67.2
201
385
F34.1
ICD-10 Finland
Dysthymia
7.8
66.8
162
232
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.5
62.4
351
1245
F60.9
ICD-10 Finland
Personality disorder, unspecified
13.5
61.9
110
88
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.1
61.3
178
327
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.5
58.6
162
278
N03AG01
ATC
valproic acid; systemic, rectal
5.7
57.7
177
347
P76
ICPC
Depressive disorder
4.0
56.4
253
737
N06AX05
ATC
trazodone; oral
11.0
56.1
110
108
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.7
54.9
148
245
F41.1
ICD-10 Finland
Generalized anxiety disorder
4.3
54.8
226
608
F61.0
ICD-10 Finland
Mixed personality disorders
11.4
54.7
105
99
N03AX16
ATC
pregabalin; oral
3.2
52.6
320
1185
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
7.7
52.1
126
178
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
10.5
51.8
104
107
T05
ICPC
Feeding problem of adult
17.4
51.4
82
50
N05BE01
ATC
buspirone; oral
10.8
50.8
100
99
N05CD07
ATC
temazepam; oral
6.8
50.4
133
213
F31.8
ICD-10 Finland
Other bipolar affective disorders
8.9
49.8
110
134
N05CF02
ATC
zolpidem; oral
3.2
49.8
309
1155
N05AA02
ATC
levomepromazine; systemic
8.8
49.6
110
135
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.8
49.1
148
282
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
8.0
48.8
115
156
N05BA01
ATC
diazepam; systemic, rectal
3.8
47.7
226
683
N06AX21
ATC
duloxetine; oral
3.7
47.5
230
707
P29
ICPC
Psychological sympt/compl other
3.7
47.3
229
704
N06AX03
ATC
mianserin; oral
9.0
46.9
102
121
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.4
46.5
129
221
R4190
NOMESCO Finland
Nutritional therapy
8.0
46.4
109
147
P01
ICPC
Feeling anxious/nervous/tense
2.6
44.8
412
1958
N06AX26
ATC
vortioxetine; oral
4.1
44.4
188
512
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.8
43.9
130
242
C07AA05
ATC
propranolol; systemic
2.6
43.8
387
1793
E66.01
ICD-10 Finland
Obesity due to excess calories
3.4
42.7
232
776
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.8
42.6
126
234
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
7.5
42.2
103
147
F40.1
ICD-10 Finland
Social phobias
5.6
41.4
127
246
F50.4
ICD-10 Finland
Overeating associated with other psychological disturbances
420.2
41.4
41
*
N03AX11
ATC
topiramate; oral
6.2
41.2
116
202
P03
ICPC
Feeling depressed
2.7
41.1
326
1410
N07BB01
ATC
disulfiram; oral
7.2
40.9
103
154
F32.1
ICD-10 Finland
Moderate depressive episode
3.6
40.9
203
633
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
7.3
40.2
100
147
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
10.4
40.1
80
81
F50
ICD-10 Finland
Eating disorders
144.5
40.0
42
*
N05AF03
ATC
chlorprothixene; systemic
8.8
39.1
86
104
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
9.3
38.7
82
93
N06AB08
ATC
fluvoxamine; oral
10.4
38.6
77
78
N06AB05
ATC
paroxetine; oral
4.3
38.5
151
381
N05AN01
ATC
lithium; oral
7.3
38.3
95
139
T82
ICPC
Obesity
4.8
38.2
134
302
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
5.0
38.1
129
280
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
37.8
294
1248
N05AB03
ATC
perphenazine; systemic, rectal
8.0
37.7
88
117
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
7.0
37.6
96
146
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.6
36.9
98
158
IER01
NOMESCO Finland
Psychoeducation, group
19.7
36.4
55
29
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
15.8
36.0
59
39
G47.3
ICD-10 Finland
Sleep apnoea
3.3
35.9
204
701
E87.6
ICD-10 Finland
Hypokalaemia
13.8
35.7
62
47
N05BA06
ATC
lorazepam; systemic, sublingual
6.8
35.7
93
146
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.1
35.3
81
105
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.6
34.2
104
199
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.7
34.1
123
285
E66.9
ICD-10 Finland
Obesity, unspecified
4.9
33.9
116
254
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.1
33.3
94
164
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.2
33.0
106
216
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.9
32.7
95
172
3075B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]
+∞
32.4
31
*
IBZ05
NOMESCO Finland
Evaluation of patient with eating disorder
+∞
32.4
31
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.7
32.0
256
1095
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
44.5
32.0
39
9
RD210
NOMESCO Finland
NA
7.7
31.2
74
101
A02BC02
ATC
pantoprazole; systemic
2.0
31.1
720
4986
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.1
30.1
125
331
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.8
30.0
105
235
N06AA12
ATC
doxepin; systemic
7.2
29.9
74
108
N06BA04
ATC
methylphenidate; oral
4.6
29.7
107
247
N06AX22
ATC
agomelatine; oral
5.9
29.1
84
151
P74
ICPC
Anxiety disorder/anxiety state
3.3
29.1
155
505
F50.5
ICD-10 Finland
Vomiting associated with other psychological disturbances
298.2
28.9
29
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.0
28.9
73
110
SPAT1240
SPAT
Therapeutic discussion
2.3
28.4
313
1575
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
6.5
28.2
75
121
R63.0
ICD-10 Finland
Anorexia
39.9
28.1
35
9
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
7.2
28.0
69
100
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.6
27.9
83
155
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
8.0
27.7
64
84
R4110
NOMESCO Finland
Physiotherapy
2.3
27.7
300
1492
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
6.4
27.6
74
121
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.4
27.5
141
445
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
7.6
26.9
64
88
N05BA12
ATC
alprazolam; oral
3.2
26.7
152
519
P99
ICPC
Psychological disorders other
4.5
26.3
97
229
F93.89
ICD-10 Finland
Other childhood emotional disorders
6.9
26.3
67
102
N06AG02
ATC
moclobemide; oral
5.7
26.3
78
145
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
25.7
292
1482
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.0
25.5
106
281
E66.00
ICD-10 Finland
Metabolic syndrome
5.0
25.4
84
177
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
25.0
103
271
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.3
24.8
131
423
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.7
24.8
73
135
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
24.5
778
5806
Z71.8
ICD-10 Finland
Other specified counselling
2.0
24.5
431
2617
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
24.2
587
3994
F33
ICD-10 Finland
Recurrent depressive disorder
5.0
24.2
80
169
N03AE01
ATC
clonazepam; systemic
4.3
24.0
91
221
F33.8
ICD-10 Finland
Other recurrent depressive disorders
8.8
23.7
51
60
WX110
NOMESCO Finland
Local anesthesy
1.9
23.7
1013
8320
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
23.5
125
405
AA400
NOMESCO Finland
Electroconvulsive therapy
10.3
23.4
46
46
N02AX02
ATC
tramadol; systemic, rectal
1.9
23.3
406
2449
G03DB01
ATC
dydrogesterone; oral
2.2
23.0
276
1426
A10BA02
ATC
metformin; oral
2.5
22.9
199
878
F32
ICD-10 Finland
Depressive episode
2.9
22.9
152
573
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
22.9
301
1618
N06AA06
ATC
trimipramine; systemic
7.7
22.8
53
71
F31
ICD-10 Finland
Bipolar affective disorder
7.3
22.8
55
78
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.1
22.4
55
80
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.4
22.3
112
348
R4140
NOMESCO Finland
Psychotherapy
10.8
21.9
42
40
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
21.7
149
571
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
21.6
229
1117
P15
ICPC
Chronic alcohol abuse
6.7
21.5
55
85
A06AD11
ATC
lactulose; oral
3.1
21.4
124
427
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
21.4
480
3142
E66
ICD-10 Finland
Obesity
3.5
21.3
103
310
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
9.6
21.2
43
46
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
21.1
352
2074
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
20.9
20
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
20.7
250
1288
P06
ICPC
Sleep disturbance
2.5
20.7
178
781
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
20.6
174
752
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
20.6
229
1140
K03.2
ICD-10 Finland
Erosion of teeth
5.2
20.5
64
127
H03AA01
ATC
levothyroxine sodium; systemic
2.0
20.4
312
1775
SPAT1139
SPAT
Nutrition survey
4.5
20.4
74
173
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
20.2
174
760
R53
ICD-10 Finland
Malaise and fatigue
2.0
19.9
315
1811
A04
ICPC
Weakness/tiredness general
2.2
19.9
235
1200
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.8
19.8
514
3509
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
10.5
19.7
38
37
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
12.4
19.6
35
29
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
5.6
19.5
57
105
R02
ICPC
Shortness of breath/dyspnoea
2.5
19.2
160
687
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
19.2
717
5435
L17
ICPC
Foot/toe symptom/complaint
1.9
19.0
315
1839
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
6.6
19.0
49
77
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
18.9
271
1498
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.7
18.8
83
232
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
18.8
1052
8977
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.4
18.4
93
290
T90
ICPC
Diabetes non-insulin dependent
2.7
18.4
135
540
D01
ICPC
Abdominal pain/cramps general
2.1
18.3
226
1173
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
18.3
490
3354
R5599
NOMESCO Finland
Other rehabilitation service
5.3
18.0
55
107
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
13.2
18.0
31
24
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.1
17.7
48
81
WX290
NOMESCO Finland
Other blockade of nerve
1.7
17.6
779
6128
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
17.6
534
3780
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.7
17.5
128
510
N05AE04
ATC
ziprasidone; systemic
9.2
17.5
36
40
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
12.2
17.4
31
26
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
17.4
159
715
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
17.3
88
277
IBA03
NOMESCO Finland
Psychotherapy evaluation
5.9
17.2
48
84
L03
ICPC
Low back symptom/complaint
1.8
17.2
353
2211
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
17.1
338
2088
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
17.1
562
4062
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
17.0
796
6326
M79.6
ICD-10 Finland
Pain in limb
1.7
17.0
420
2789
F41.00
ICD-10 Finland
Moderate panic disorder
4.2
16.9
65
161
R51.80
ICD-10 Finland
Headache
1.9
16.9
271
1557
R5140
NOMESCO Finland
Monitoring the use of the aid
3.4
16.9
83
254
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
7.3
16.9
40
56
K02.1
ICD-10 Finland
Caries of dentine
1.7
16.7
883
7237
N06AX18
ATC
reboxetine; oral
9.9
16.7
33
34
S18
ICPC
Laceration/cut
1.7
16.5
405
2679
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
10.9
16.5
31
29
C03CA01
ATC
furosemide; systemic
2.8
16.4
112
430
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.5
16.3
42
66
F45.8
ICD-10 Finland
Other somatoform disorders
2.2
16.1
182
906
IEY01
NOMESCO Finland
Psychoeducation, individual
7.4
16.1
38
53
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
24.8
16.0
22
9
RF220
NOMESCO Finland
NA
9.1
16.0
33
37
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
16.0
239
1336
F60.8
ICD-10 Finland
Other specific personality disorders
7.8
15.9
36
47
K59.0
ICD-10 Finland
Constipation
3.5
15.6
74
221
N02BE01
ATC
paracetamol; systemic, rectal
1.7
15.6
1053
9148
AA1AD
NOMESCO Finland
CT of head and brain
2.2
15.5
174
863
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.5
15.4
74
223
E11
ICD-10 Finland
Type 2 diabetes mellitus
3.1
15.4
88
301
WX002
NOMESCO Finland
Sedation and analgesia
2.1
15.3
182
925
N05AD01
ATC
haloperidol; systemic
6.3
15.2
40
65
X78
ICD-10 Finland
Intentional self-harm by sharp object
8.2
15.1
33
41
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
15.0
204
1094
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
9.6
15.0
30
32
F60.5
ICD-10 Finland
Anankastic personality disorder
5.9
14.9
41
71
N06AA09
ATC
amitriptyline; systemic
2.9
14.8
92
334
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
9.9
14.7
29
30
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
14.7
119
504
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
7.4
14.5
34
47
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.4
14.5
52
121
N05AH02
ATC
clozapine; systemic
5.3
14.5
44
86
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
14.3
438
3058
C07AB07
ATC
bisoprolol; oral
1.8
14.3
263
1576
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
14.3
224
1268
SPAT1389
SPAT
Visit based on need for special support
2.6
14.3
107
434
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.1
14.2
77
255
H01
ICPC
Ear pain/earache
2.0
14.2
207
1142
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
14.1
235
1359
SFA00
NOMESCO Finland
Small filling
2.1
14.0
173
890
R06.0
ICD-10 Finland
Dyspnoea
1.9
14.0
236
1373
L12
ICPC
Hand/finger symptom/complaint
2.0
14.0
204
1124
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
14.0
173
893
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
3.1
13.9
79
268
L08
ICPC
Shoulder symptom/complaint
2.1
13.9
175
911
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
8.3
13.8
30
37
K59.09
ICD-10 Finland
Constipation, unspecified
3.8
13.8
59
162
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
13.8
246
1457
WX722
NOMESCO Finland
PEEP
5.1
13.8
43
87
F32.8
ICD-10 Finland
Other depressive episodes
4.4
13.7
49
114
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.2
13.7
51
124
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
13.6
158
793
RT230
NOMESCO Finland
NA
75.9
13.6
15
*
N01
ICPC
Headache
1.8
13.6
262
1594
EBA00
NOMESCO Finland
Extraction of tooth
1.6
13.6
481
3479
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
7.3
13.6
32
45
L28
ICPC
Limited function/disability (L)
2.4
13.6
118
519
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
6.4
13.6
35
56
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.1
13.5
52
130
G04BD12
ATC
mirabegron; oral
3.5
13.5
63
186
A08AB01
ATC
orlistat; oral
34.4
13.5
17
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
13.3
59
168
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.3
13.2
40
78
P01AB01
ATC
metronidazole; oral, rectal
1.6
13.1
509
3763
J01DB01
ATC
cefalexin; oral
1.7
13.1
1076
9537
N05AF01
ATC
flupentixol; systemic
7.5
13.0
30
41
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
12.9
203
1148
A02BC01
ATC
omeprazole; systemic
1.7
12.9
284
1797
R74
ICPC
Upper respiratory infection acute
1.5
12.8
569
4336
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
2.6
12.8
97
395
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
10.6
12.8
24
23
F10.24
ICD-10 Finland
Alcohol depence active use
6.9
12.7
31
46
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
12.6
580
4450
D11
ICPC
Diarrhoea
1.8
12.6
221
1297
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
11.1
12.5
23
21
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
9.4
12.5
25
27
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
6.4
12.5
32
51
X84
ICD-10 Finland
Intentional self-harm by unspecified means
13.3
12.4
21
16
M01AB05
ATC
diclofenac; systemic, rectal
1.5
12.3
727
5892
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
12.3
418
2979
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.8
12.3
34
60
N05BA02
ATC
chlordiazepoxide; systemic
7.5
12.2
28
38
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.8
12.2
80
300
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.8
12.2
237
1438
L16
ICPC
Ankle symptom/complaint
2.0
12.1
154
803
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
12.1
136
673
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
12.0
223
1334
ZXA05
NOMESCO Finland
Left side
1.9
12.0
180
1001
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.4
12.0
35
66
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
12.0
245
1513
N03AX12
ATC
gabapentin; oral
2.1
12.0
148
762
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.9
11.9
29
43
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
11.9
240
1475
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.8
11.9
49
131
S06.0
ICD-10 Finland
Concussion
2.1
11.8
141
715
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
7.1
11.8
28
40
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.9
11.8
70
247
R42
ICD-10 Finland
Dizziness and giddiness
1.8
11.8
206
1210
F61
ICD-10 Finland
Mixed and other personality disorders
9.7
11.8
23
24
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
3.7
11.7
51
143
M79.1
ICD-10 Finland
Myalgia
1.9
11.7
197
1139
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
12.7
11.6
20
16
N89
ICPC
Migraine
2.3
11.6
108
491
N17
ICPC
Vertigo/dizziness
2.1
11.6
127
623
N06AA04
ATC
clomipramine; systemic
6.6
11.6
29
45
RS220
NOMESCO Finland
NA
5.3
11.5
34
65
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
11.5
205
1212
A08
ICPC
Swelling
4.0
11.4
45
116
R03AC02
ATC
salbutamol; inhalant
1.5
11.4
681
5491
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.0
11.4
27
39
S29
ICPC
Skin symptom/complaint other
1.8
11.3
197
1153
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
11.3
57
180
N05AA01
ATC
chlorpromazine; systemic, rectal
8.4
11.3
24
29
F60.0
ICD-10 Finland
Paranoid personality disorder
9.7
11.3
22
23
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
11.2
70
255
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
25.2
11.1
15
6
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
6.5
11.1
28
44
T08
ICPC
Weight loss
6.5
11.1
28
44
R60.0
ICD-10 Finland
Localized oedema
2.5
11.1
87
362
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
11.1
290
1920
K62.3
ICD-10 Finland
Rectal prolapse
8.6
11.0
23
27
A02BC05
ATC
esomeprazole; systemic
1.6
11.0
378
2684
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
7.5
11.0
25
34
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
11.0
228
1411
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.9
10.9
162
897
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.9
10.9
165
917
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
10.8
306
2069
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.0
10.7
145
776
160
Kela drug reimbursment
exenatide
7.6
10.7
24
32
A02BA02
ATC
ranitidine; systemic
2.0
10.7
135
703
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.7
10.6
35
76
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.7
10.6
242
1540
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
10.6
138
726
A01
ICPC
Pain general/multiple sites
2.3
10.6
100
456
R11
ICD-10 Finland
Nausea and vomiting
2.1
10.6
126
641
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
5.1
10.5
32
64
L02
ICPC
Back symptom/complaint
1.9
10.5
151
827
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
10.4
189
1119
WX110
SPAT
NA
2.4
10.4
85
361
R4120
NOMESCO Finland
Occupational therapy
2.6
10.4
73
287
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
16.2
10.4
16
10
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
10.3
170
976
M79.7
ICD-10 Finland
Fibromyalgia
2.9
10.3
62
222
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
10.3
420
3098
N06BA12
ATC
lisdexamfetamine; oral
6.7
10.2
25
38
G44.2
ICD-10 Finland
Tension-type headache
1.7
10.2
210
1297
G04BD08
ATC
solifenacin; oral
3.7
10.2
43
119
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
10.1
788
6641
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
4.3
10.1
36
85
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
8.0
10.1
22
28
T83
ICPC
Overweight
3.5
10.1
46
135
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
11.4
10.1
18
16
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
5.2
10.0
30
59
A28
ICPC
Limited function/disability NOS
2.7
10.0
70
272
P28
ICPC
Limited function/disability (P)
6.1
10.0
26
43
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.8
10.0
189
1136
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.5
10.0
78
326
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
10.0
359
4745
J01FF01
ATC
clindamycin; systemic
1.6
9.9
288
1954
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
9.8
105
508
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
7.1
9.8
23
33
X23
ICPC
Fear sexually transm dis female
1.7
9.8
205
1268
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
9.8
149
829
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
9.7
78
328
WX892
NOMESCO Finland
Monitored bed care
2.6
9.7
68
266
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
9.7
213
1338
R03BA02
ATC
budesonide; inhalant
1.7
9.6
219
1387
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.0
9.6
117
600
D06
ICPC
Abdominal pain localized other
1.9
9.6
142
782
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
9.6
106
523
T07
ICPC
Weight gain
4.4
9.6
33
76
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.7
9.5
31
67
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
9.2
9.5
19
21
R96
ICPC
Asthma
2.1
9.5
105
516
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
9.5
287
1963
A10BH01
ATC
sitagliptin; oral
3.4
9.5
45
137
M54.5
ICD-10 Finland
Low back pain
1.5
9.4
418
3123
N05AE05
ATC
lurasidone; oral
7.6
9.4
21
28
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
17.7
9.4
14
8
S97
ICPC
Chronic ulcer skin
4.2
9.4
34
82
G43.9
ICD-10 Finland
Migraine, unspecified
1.9
9.4
135
738
X58
ICD-10 Finland
Exposure to other specified factors
1.8
9.4
165
966
E66.0
ICD-10 Finland
Obesity due to excess calories
7.0
9.3
22
32
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.9
9.3
138
762
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
8.7
9.3
19
22
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
8.7
9.3
19
22
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
6.1
9.2
24
40
K59.1
ICD-10 Finland
Functional diarrhoea
2.6
9.2
67
271
WZA90
NOMESCO Finland
Other doctors statement
1.5
9.2
325
2309
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
9.1
183
1115
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
9.1
125
669
S76
ICPC
Skin infection other
2.8
9.1
57
208
D12
ICPC
Constipation
3.8
9.1
37
100
N05AD03
ATC
melperone; systemic
9.1
9.0
18
20
J02AC01
ATC
fluconazole; systemic
1.4
9.0
602
4874
B01AB05
ATC
enoxaparin; parenteral
1.6
9.0
247
1649
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
24.2
8.9
12
5
P58
ICPC
Psychological, Therapeutic counselling/listening
3.1
8.9
48
161
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
8.9
224
1459
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
8.9
84
385
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
12.6
8.9
15
12
R03AC03
ATC
terbutaline; inhalant
1.7
8.8
177
1078
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
8.8
207
1325
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
10.8
8.8
16
15
Z07
ICPC
Education problem
4.1
8.8
33
83
IGV01
NOMESCO Finland
Psychiatric network contact
5.4
8.8
25
47
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
8.8
200
1266
A10BJ06
ATC
semaglutide; parenteral
3.8
8.8
35
93
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.9
8.7
52
186
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
7.2
8.7
20
28
N05AH05
ATC
asenapine; oral
14.1
8.7
14
10
RD112
NOMESCO Finland
NA
14.1
8.7
14
10
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.5
8.7
66
272
EB1SA
SPAT
NA
2.4
8.7
69
291
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
8.6
78
352
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.8
8.6
152
891
F32.0
ICD-10 Finland
Mild depressive episode
2.7
8.6
58
221
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.8
8.6
138
784
Z01.7
ICD-10 Finland
Laboratory examination
1.9
8.6
134
751
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
5.5
8.6
24
44
A10AE04
ATC
insulin glargine; parenteral
2.3
8.6
79
357
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.4
8.5
71
306
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
9.0
8.5
17
19
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.5
741
6278
N76.0
ICD-10 Finland
Acute vaginitis
1.7
8.5
168
1022
E0000UV
ATC
NA
1.4
8.5
510
4035
L60.0
ICD-10 Finland
Ingrowing nail
2.6
8.5
59
232
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
5.2
8.5
25
49
SGA01
NOMESCO Finland
Tooth opening as first aid
1.6
8.5
230
1529
-58
ICPC
Therapeutic counselling/listening
5.7
8.5
23
41
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.4
147
861
C07AB02
ATC
metoprolol; systemic
2.0
8.4
104
539
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
3.0
8.4
45
151
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.4
90
438
L13
ICPC
Hip symptom/complaint
1.9
8.3
115
618
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
+∞
8.3
8
*
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.0
8.3
101
518
F60.7
ICD-10 Finland
Dependent personality disorder
8.6
8.3
17
20
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.6
8.3
35
98
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.9
8.3
128
719
N05AL01
ATC
sulpiride; systemic
7.1
8.3
19
27
N03AF02
ATC
oxcarbazepine; oral
3.2
8.2
42
136
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.5
8.2
20
31
P27
ICPC
Fear of mental disorder
3.6
8.2
35
99
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
7.6
8.2
18
24
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
7.6
8.2
18
24
IGY02
SPAT
NA
6.1
8.2
21
35
A10BJ02
ATC
liraglutide; parenteral
4.7
8.1
26
56
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
2.0
8.1
97
493
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.5
8.1
36
105
N30.0
ICD-10 Finland
Acute cystitis
1.6
8.1
195
1256
EB1AA
SPAT
NA
2.4
8.1
68
296
U04
ICPC
Incontinence urine
3.4
8.1
37
111
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
9.0
8.0
16
18
N03AF01
ATC
carbamazepine; oral, rectal
3.0
8.0
44
150
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
10.1
8.0
15
15
N06BA09
ATC
atomoxetine; oral
10.1
8.0
15
15
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
4.2
8.0
29
71
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
5.9
8.0
21
36
K04.0
ICD-10 Finland
Pulpitis
1.7
8.0
166
1025
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
8.0
70
311
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
7.9
34
97
R32
ICD-10 Finland
Unspecified urinary incontinence
4.1
7.9
29
72
E03
ICD-10 Finland
Other hypothyroidism
2.3
7.9
72
325
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
13.1
7.9
13
10
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
7.8
7.9
17
22
M03BX02
ATC
tizanidine; oral
1.4
7.9
710
6017
R1250
NOMESCO Finland
Evaluation of functional capability
4.0
7.9
30
77
A03FA02
ATC
cisapride; oral, rectal
2.5
7.9
58
236
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
7.8
57
228
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
7.8
140
825
R2110
NOMESCO Finland
Giving the first information
1.9
7.8
119
666
RS210
NOMESCO Finland
NA
8.5
7.8
16
19
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
9.5
7.8
15
16
K03.00
ICD-10 Finland
Approximal wear
2.2
7.8
77
363
N06
ICPC
Sensation disturbance other
4.9
7.8
24
50
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.8
7.8
129
741
A99
ICPC
Disease/condition unspecnature/site
2.1
7.7
90
453
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.4
7.7
35
104
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.7
973
8735
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.8
7.7
49
182
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
7.7
84
414
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
5.3
7.7
22
42
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
2.4
7.7
61
259
XCK10
NOMESCO Finland
Photography of fundus of eye
2.3
7.7
71
323
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.0
7.7
29
74
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
7.7
38
121
L14
ICPC
Leg/thigh symptom/complaint
2.2
7.7
73
336
A91
ICPC
Abnormal result investigation NOS
2.9
7.6
44
154
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
7.6
160
991
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.6
256
1792
N05AB01
ATC
dixyrazine; systemic
8.1
7.6
16
20
W19
ICD-10 Finland
Unspecified fall
2.0
7.6
93
478
A29
ICPC
General symptom/complaint other
1.9
7.6
113
627
R52.9
ICD-10 Finland
Pain, unspecified
2.0
7.6
97
507
H3601, E103
ICD-10 Finland
NA
5.2
7.6
22
43
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.8
7.5
129
750
C10AA01
ATC
simvastatin; oral
1.9
7.5
107
584
G04CA02
ATC
tamsulosin; oral
3.2
7.5
38
123
LCH11
NOMESCO Finland
Pharmacologic abortion
1.8
7.5
139
828
WX290
SPAT
NA
2.5
7.5
56
230
ICA04
NOMESCO Finland
Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution
7.2
7.5
17
24
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
7.2
7.5
17
24
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
3.9
7.5
29
76
L84
ICPC
Back syndrome without radiat pain
2.4
7.5
59
250
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.5
7.5
25
57
A27
ICPC
Fear of other disease NOS
2.5
7.4
58
243
P80
ICPC
Personality disorder
5.1
7.4
22
44
3075A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[TARKEMMIN MÄÄRITTELEMÄTÖN SYÖMISHÄIRIÖ]
80.5
7.4
8
*
T06
ICPC
ANOREXIA NERVOSA W/WO BULIMIA
80.5
7.4
8
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
7.4
333
2478
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
7.4
319
2351
X14
ICPC
Vaginal discharge
2.2
7.4
69
316
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
7.7
7.4
16
21
ICB01
SPAT
NA
13.4
7.4
12
9
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
13.4
7.4
12
9
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
5.6
7.4
20
36
D18
ICPC
Change in faeces/bowel movements
3.8
7.4
29
77
L01
ICPC
Neck symptom/complaint
1.6
7.4
191
1252
R06AE07
ATC
cetirizine; oral
1.4
7.4
598
4957
R33
ICD-10 Finland
Retention of urine
3.5
7.3
32
93
XG466
NOMESCO Finland
Sleep oxymetry
4.2
7.3
26
63
S01.0
ICD-10 Finland
Open wound of scalp
2.7
7.3
48
184
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
7.3
291
2111
RS214
NOMESCO Finland
NA
10.9
7.3
13
12
J45
ICD-10 Finland
Asthma
1.8
7.3
118
673
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
6.9
7.3
17
25
K04.00
ICD-10 Finland
Hyperemia of pulp
2.1
7.3
78
380
M25.5
ICD-10 Finland
Pain in joint
1.5
7.3
324
2403
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
9.4
7.3
14
15
U02
ICPC
Urinary frequency/urgency
1.6
7.3
175
1123
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
2.5
7.3
54
221
L20
ICPC
Joint symptom/complaint NOS
2.6
7.3
51
203
N06AX17
ATC
milnacipran; oral
5.2
7.3
21
41
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.0
7.3
40
138
UJH02
NOMESCO Finland
Anoscopy
2.8
7.2
43
155
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.3
7.2
25
59
KMAK
NOMESCO Finland
NA
1.4
7.2
749
6459
F21
ICD-10 Finland
Schizotypal disorder
7.3
7.2
16
22
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
7.3
7.2
16
22
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.3
7.2
16
22
P11
ICPC
Eating problem in child
30.2
7.2
9
*
L15
ICPC
Knee symptom/complaint
1.6
7.1
196
1303
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.4
7.1
56
235
D07AA02
ATC
hydrocortisone; topical
1.6
7.1
216
1473
Z29
ICPC
Social problem NOS
2.8
7.1
43
158
S51.7
ICD-10 Finland
Multiple open wounds of forearm
8.8
7.1
14
16
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
4.3
7.0
24
56
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
7.0
34
107
SPAT1324
SPAT
Screening procedure
0.6
7.0
167
2423
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.0
7.0
16
23
P19
ICPC
Drug abuse
3.9
7.0
27
71
Z00.0
ICD-10 Finland
General medical examination
1.5
7.0
224
1546
R05
ICPC
Cough
1.5
7.0
287
2096
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
6.9
58
253
P16
ICPC
Acute alcohol abuse
4.3
6.9
24
57
SPAT1260
SPAT
Consultation of another employee
1.6
6.9
208
1412
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
3.9
6.9
26
67
EAV
NOMESCO Finland
NA
3.2
6.9
34
109
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
6.9
209
1423
H02AB06
ATC
prednisolone; systemic
1.4
6.9
447
3553
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
6.9
94
506
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.8
121
712
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.4
6.8
54
228
M54
ICD-10 Finland
Dorsalgia
1.7
6.8
146
911
H3602, E103
ICD-10 Finland
NA
11.0
6.8
12
11
K04
ICPC
Palpitations/awareness of heart
2.2
6.8
65
302
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
9.4
6.8
13
14
M01AB01
ATC
indometacin; systemic, rectal
3.8
6.8
27
73
R52.2
ICD-10 Finland
Other chronic pain
2.8
6.8
40
144
IEV99
NOMESCO Finland
Other psychiatric network intervention
6.1
6.8
17
28
A46
ICD-10 Finland
Erysipelas
2.1
6.8
74
363
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.5
6.7
51
212
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
6.7
34
111
JGC01
NOMESCO Finland
Laparoscopic rectopexy
7.2
6.7
15
21
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
22.6
6.7
9
*
F53.0
ICD-10 Finland
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
22.6
6.7
9
*
C09AA05
ATC
ramipril; oral
2.0
6.7
82
423
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
6.7
84
438
N05BB01
ATC
hydroxyzine; systemic
1.9
6.6
88
467
A03
ICPC
Fever
1.5
6.6
293
2164
N04AA02
ATC
biperiden; systemic
4.2
6.6
23
55
V03AA01
ATC
NA
7.8
6.6
14
18
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.7
6.6
27
75
N05AC01
ATC
periciazine; systemic
12.3
6.6
11
9
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
12.3
6.6
11
9
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.7
6.6
147
928
K08.80
ICD-10 Finland
Toothache NOS
1.7
6.5
122
729
A10BB12
ATC
glimepiride; oral
5.1
6.5
19
38
SPAT1234
SPAT
Support of social functional capacity
2.7
6.5
42
160
G43
ICD-10 Finland
Migraine
1.8
6.4
109
633
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.3
6.4
22
52
30650
ICD-8 Finland
Special symptoms not elsewhere classified, Feeding disturbance
70.2
6.4
7
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.4
318
2401
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.4
6.4
14
19
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
2.1
6.4
67
324
S01
ICPC
Pain/tenderness of skin
2.5
6.4
46
187
W12
ICPC
Contraception intrauterine
1.4
6.3
287
2131
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
6.6
6.3
15
23
ZXA00
NOMESCO Finland
Right side
1.6
6.3
167
1099
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.5
6.3
46
189
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
9.3
6.3
12
13
RS140
NOMESCO Finland
NA
9.3
6.3
12
13
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
9.3
6.3
12
13
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.5
6.3
45
182
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.3
317
2402
IDR02
NOMESCO Finland
Systematic group therapy, cognitive
+∞
6.3
6
*
RT236
NOMESCO Finland
NA
+∞
6.3
6
*
C03DA01
ATC
spironolactone; oral
2.4
6.2
51
221
D10
ICPC
Vomiting
1.6
6.2
145
923
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
4.3
6.2
21
49
A13
ICPC
Concern/fear medical treatment
4.3
6.2
21
49
R03BB04
ATC
tiotropium bromide; inhalant
2.6
6.2
44
175
F41.01
ICD-10 Finland
Severe panic disorder
4.8
6.2
19
40
NH1AD
NOMESCO Finland
Ankle and foot CT
3.6
6.2
26
74
W10
ICD-10 Finland
Fall on and from stairs and steps
2.4
6.2
48
203
N92.4
ICD-10 Finland
Excessive bleeding in the premenopausal period
2.7
6.2
40
152
A10BK03
ATC
empagliflozin; oral
2.7
6.1
40
153
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
6.1
66
326
R06.4
ICD-10 Finland
Hyperventilation
3.1
6.1
31
102
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.1
61
291
OAB40
SPAT
NA
7.7
6.1
13
17
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
7.7
6.1
13
17
-60
ICPC
Result test/procedure
2.0
6.1
72
368
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.1
67
331
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.1
189
1293
RT250
NOMESCO Finland
NA
12.6
6.1
10
8
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
6.1
126
779
K80
ICPC
Cardiac arrhythmia NOS
2.2
6.1
56
259
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
4.9
6.1
18
37
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
6.0
80
428
M54.3
ICD-10 Finland
Sciatica
2.3
6.0
53
239
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
10.1
6.0
11
11
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
10.1
6.0
11
11
C05AA08
ATC
fluocortolone; rectal, topical
1.8
6.0
104
609
U05
ICPC
Urination problems other
2.8
6.0
35
125
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
6.0
152
991
C08CA01
ATC
amlodipine; oral
1.7
6.0
117
708
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
323
772
5.09
129.51
4.9
5.3
mmol/l
1.1
1.0
1.38
296
733
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
745
3253
3.64
128.62
2.2
1.6
pmol/l
99.6
99.2
0.07
436
1861
(3028707) Methadone [Presence] in Urine by Screen method
240
487
5.70
115.30
3.8
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
496
1767
3.74
114.98
2.4
1.5
%
1.4
1.3
7.49
448
1603
(3019309) Folate [Moles/volume] in Red Blood Cells
380
1176
4.02
107.42
1.8
1.6
nmol/l
1126.9
1168.6
0.39
303
918
(3015377) Calcium [Moles/volume] in Serum or Plasma
632
2800
3.22
100.88
2.7
2.6
mmol/l
2.3
2.3
0.29
555
2536
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
703
3352
3.12
98.11
5.8
4.5
mmol/l
1.2
1.2
0.25
656
3043
(3021960) Folate [Moles/volume] in Serum or Plasma
462
1775
3.35
92.37
1.7
1.4
nmol/l
21.5
20.6
0.74
418
1601
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
749
3811
2.99
91.22
6.7
5.0
mmol/l
1.2
1.2
1.31
659
3168
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
839
4546
2.99
90.89
2.9
2.2
nmol/l
70.0
71.5
0.89
784
4284
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
238
602
4.53
87.11
2.7
2.5
g/l
0.2
0.2
0.66
218
575
(3024561) Albumin [Mass/volume] in Serum or Plasma
685
3418
2.90
84.91
4.5
4.0
g/l
37.2
37.1
0.10
631
3188
(3011288) Drugs identified in Urine by Screen method
274
847
3.75
75.57
4.5
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
319
1115
3.38
72.58
3.3
3.1
mmol/l
0.8
0.8
0.19
300
1045
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
682
3641
2.64
70.62
3.5
2.7
u/l
28.9
26.6
0.64
634
3470
(3018418) pH of Serum or Plasma
485
2222
2.77
67.72
3.7
3.0
ph
7.4
7.4
0.28
60
451
(3009508) Creatinine [Moles/volume] in Urine
491
2320
2.68
63.90
4.0
3.3
mmol/l
7.5
8.0
1.21
418
2041
(1001926) Buprenorphine [Presence] in Urine by Screen method
272
951
3.29
61.10
3.5
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1076
7510
2.65
58.65
7.1
5.7
u/l
70.5
69.4
0.42
1009
7045
(3016879) Cocaine [Presence] in Urine
291
1110
3.03
55.99
3.6
2.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
315
1262
2.91
55.42
2.4
2.1
mmol/l
2.4
2.4
0.68
261
1082
(3000764) Benzodiazepines [Presence] in Urine
306
1208
2.94
55.30
3.5
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
307
1219
2.92
54.86
3.5
1.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1306
10263
3.63
53.87
5.9
4.2
pmol/l
13.7
14.2
14.80
1228
9607
(3027008) Opiates [Presence] in Urine
304
1216
2.90
53.48
3.5
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
530
2792
2.41
52.93
2.3
2.0
mg/l
2.7
2.6
1.04
438
2405
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1384
11591
4.87
45.49
7.2
4.7
mu/l
1.7
1.8
0.63
1333
11079
(3027944) Amphetamines [Presence] in Urine
286
1199
2.72
45.42
3.1
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1347
11143
3.77
43.70
15.4
7.6
mmol/l
3.9
3.9
0.57
1318
10729
(3019550) Sodium [Moles/volume] in Serum or Plasma
1345
11117
3.73
43.68
15.2
7.6
mmol/l
139.3
139.4
0.87
1317
10742
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
70
108
6.76
43.68
12.7
12.0
mmol/l
0.6
0.6
0.11
64
101
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
87
167
5.48
43.51
2.4
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
887
6118
2.15
42.78
3.6
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
525
2961
2.21
42.75
3.2
2.2
u/l
59.1
54.4
2.11
467
2748
(44816559) Phosphatidylethanol [Mass/volume] in Blood
115
288
4.25
41.78
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1026
7527
2.23
41.74
3.7
2.9
ug/l
51.2
53.7
0.50
968
7131
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
44
40
11.31
41.68
6.0
4.1
umol/l
143.0
107.3
0.35
23
22
(3036481) Cortisol [Moles/volume] in Serum or Plasma
259
1090
2.67
40.49
2.0
2.0
nmol/l
383.0
390.8
0.23
233
996
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
612
3741
2.10
39.81
1.5
1.3
u/ml
0.8
1.7
2.62
161
1059
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1110
8529
2.27
38.42
4.1
2.5
u/l
28.9
28.5
0.13
1052
8200
(42870588) Differential panel, method unspecified - Blood
569
3449
2.07
37.26
5.7
5.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
706
4626
2.02
37.20
5.0
4.4
umol/l
9.3
9.4
0.02
633
4294
(3033658) Prothrombin time (PT) actual/Normal
423
2306
2.18
36.50
3.9
3.2
%
99.4
98.9
0.17
409
2221
(3013826) Glucose [Moles/volume] in Serum or Plasma
823
5730
2.00
36.09
5.0
3.8
mmol/l
6.2
6.1
1.04
762
4934
(3013650) Neutrophils [#/volume] in Blood by Automated count
898
6447
2.02
36.07
9.8
7.4
e9/l
3.9
4.0
0.34
759
5681
(3006315) Basophils [#/volume] in Blood
812
5651
1.99
35.37
6.0
5.4
e9/l
0.0
0.0
0.14
689
5017
(3013115) Eosinophils [#/volume] in Blood
836
5882
1.99
35.22
6.4
5.6
e9/l
0.2
0.2
0.60
729
5312
(3022096) Basophils/100 leukocytes in Blood
751
5106
1.97
34.81
6.2
5.5
%
0.7
0.7
0.29
691
4762
(3001604) Monocytes [#/volume] in Blood
808
5636
1.97
34.71
6.0
5.4
e9/l
0.5
0.5
0.15
688
5015
(3019198) Lymphocytes [#/volume] in Blood
838
5930
1.97
34.38
5.9
5.3
e9/l
2.0
2.0
0.14
737
5394
(3006504) Eosinophils/100 leukocytes in Blood
773
5334
1.96
34.02
6.0
5.3
%
2.5
2.6
0.76
716
4966
(3019069) Monocytes/100 leukocytes in Blood
777
5371
1.96
34.02
6.3
5.5
%
7.6
7.7
0.43
726
5058
(3013707) Erythrocyte sedimentation rate by Westergren method
1066
8243
2.09
33.55
3.8
3.4
mm/h
9.9
8.5
3.71
997
7727
(3002030) Lymphocytes/100 leukocytes in Blood
809
5687
1.95
33.50
6.0
5.2
%
29.5
30.0
0.96
754
5344
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1256
10386
2.52
33.24
4.6
2.9
mmol/l
5.6
5.5
2.51
1184
9765
(3018010) Neutrophils/100 leukocytes in Blood
797
5615
1.93
32.34
5.9
5.1
%
57.0
56.6
0.46
745
5286
(40758558) Short blood count panel - Blood
446
2604
2.03
31.28
6.5
5.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1263
10557
2.47
31.09
11.6
6.8
ml/min/173m2
99.9
99.3
0.55
998
8332
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
209
898
2.55
30.83
2.5
2.2
u/l
34.5
34.8
0.03
177
744
(3002032) Base excess in Venous blood by calculation
141
495
3.05
30.58
5.0
3.5
mmol/l
1.6
1.7
0.10
121
390
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
100
288
3.65
29.79
5.5
3.8
mmol/l
24.3
24.1
0.31
93
257
(3000991) Gas panel - Venous blood
132
453
3.10
29.75
9.4
8.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
377
2114
2.06
29.27
2.2
1.9
u/l
142.7
156.7
0.17
363
2007
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
326
1754
2.11
28.16
1.8
1.5
pmol/l
422.0
37676023.3
1.78
281
1566
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
35
41
8.72
27.59
1.4
2.2
umol/l
12.8
13.8
0.22
35
41
(3014111) Lactate [Moles/volume] in Serum or Plasma
140
519
2.88
27.48
6.6
6.2
mmol/l
1.2
1.2
0.12
134
493
(3007164) IgA [Mass/volume] in Serum or Plasma
497
3134
1.89
27.05
1.5
1.4
g/l
2.0
2.0
0.12
262
2019
(3022948) Iron [Moles/volume] in Serum or Plasma
264
1351
2.17
25.76
2.4
2.1
umol/l
14.4
15.0
0.57
246
1238
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1395
12506
3.71
25.49
11.0
7.1
u/l
25.5
23.1
1.30
1359
12113
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
224
1078
2.27
25.41
2.6
2.2
%
23.2
24.3
0.51
197
917
(3004789) Transferrin [Mass/volume] in Serum or Plasma
243
1210
2.21
25.37
2.4
2.1
g/l
2.5
2.5
0.77
219
1103
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
120
4.81
24.67
6.2
5.7
umol/l
371.6
360.1
0.12
48
103
(4198724)
48
93
5.30
23.72
4.0
4.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
238
1215
2.15
23.20
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
136
542
2.66
23.18
6.9
9.3
mmol/l
0.5
0.5
0.01
108
379
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
257
1354
2.09
23.06
2.9
2.3
e6/l
5.5
4.7
0.43
120
681
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1092
8975
1.87
22.92
5.5
3.5
mmol/mol
37.4
36.5
2.02
1023
8539
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
134
546
2.60
21.83
7.0
9.2
kpa
5.2
5.0
2.74
128
517
(3027801) Oxygen [Partial pressure] in Arterial blood
134
546
2.60
21.83
7.0
9.2
kpa
12.2
14.3
4.25
126
519
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
81
253
3.33
21.28
8.2
9.7
mmol/l
24.0
23.6
0.55
72
239
(3052851) Hemolysis interference index of Serum or Plasma
79
246
3.34
20.86
2.5
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
689
5053
1.69
20.85
2.8
2.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
42
82
5.24
20.59
1.6
1.7
promille
1.6
1.4
0.22
30
69
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
260
1430
2.00
20.56
2.7
2.2
e6/l
1.1
1.5
0.38
124
754
(3013512) EKG study
325
1930
1.88
20.44
3.0
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
634
4568
1.69
20.36
2.6
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
343
2077
1.85
20.27
2.2
2.5
ug/g
80.5
87.5
0.22
241
1605
(3000570) Elastase.pancreatic [Mass/mass] in Stool
72
218
3.42
19.87
1.3
1.3
ug/g
313.7
326.6
0.16
35
100
(3008295) Osmolality of Serum or Plasma
36
63
5.83
19.82
3.4
2.0
mosm/kgh2o
287.6
287.4
0.01
28
49
(3021387) Prolactin [Units/volume] in Serum or Plasma
235
1275
2.01
19.22
1.6
1.6
mu/l
346.9
299.3
0.94
198
1132
(3020779) Urea [Moles/volume] in Serum or Plasma
116
473
2.58
18.84
6.0
6.9
mmol/l
6.2
6.3
0.09
107
455
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1359
12321
2.53
18.36
13.7
8.8
mg/l
18.3
18.3
0.02
1066
9383
(3021589) Normoblasts [#/volume] in Blood
698
5253
1.63
18.25
8.8
7.2
e9/l
0.0
0.0
2.54
532
4351
(3030467) Casts [#/volume] in Urine by Automated count
399
2597
1.74
18.21
3.4
2.5
e6/l
0.2
0.3
0.16
279
1907
(3020682) Albumin/Creatinine [Ratio] in Urine
280
1642
1.87
18.10
4.6
4.3
mg/mmol
9.6
13.2
0.66
173
1130
(3002582) Erythrocytes [#/volume] in Urine
433
2890
1.71
18.01
3.5
2.6
e6/l
260.1
66.4
0.45
315
2145
(3023368) Bacteria identified in Blood by Culture
299
1796
1.84
17.89
4.5
3.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
201
1062
2.04
17.62
2.0
2.5
ng/l
390.3
464.3
0.24
150
809
(36660697) Celiac disease serology panel - Serum
234
1310
1.94
17.38
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
542
3865
1.64
17.36
4.1
3.0
e6/l
58.5
66.1
0.13
334
2371
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
338
2.77
17.18
3.0
2.8
mmol/l
1.1
0.8
0.29
60
224
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1238
10894
1.91
17.18
4.1
3.0
mmol/l
2.7
2.8
5.20
1166
10335
(3019225) pH of Specimen
149
708
2.23
17.18
4.7
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
268
1585
1.85
16.76
3.8
3.6
mg/l
326.9
373.8
0.06
170
1092
(3009343) pH of Capillary blood
90
343
2.73
16.71
3.0
2.8
ph
7.4
7.4
—
9
48
(3015736) pH of Urine
649
4872
1.60
16.63
3.3
2.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
248
1440
1.87
16.42
2.0
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
333
2129
1.73
15.92
2.1
2.0
umol/l
1460.3
3541.7
0.89
290
1914
(3042936) Bacteria identified in Isolate by Culture
220
1241
1.91
15.89
2.1
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
203
1115
1.95
15.87
1.4
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
396
2660
1.67
15.73
3.4
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1225
10826
1.83
15.63
3.9
2.9
mmol/l
4.6
4.7
3.62
1172
10350
(3007853) Bacteria identified in Skin by Aerobe culture
217
1225
1.91
15.62
1.7
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
387
2589
1.67
15.60
2.7
2.2
ng/l
13.3
20.9
1.46
154
830
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
123
566
2.28
15.29
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
147
736
2.11
14.82
1.3
1.3
u/l
9.1
10.1
0.39
116
600
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1173
10283
1.72
14.82
3.5
2.7
mmol/l
1.2
1.1
3.23
1109
9814
(3014765) Yersinia sp identified in Stool by Organism specific culture
91
371
2.55
14.78
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
45
123
3.74
14.50
3.0
2.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
134
658
2.14
14.20
3.0
2.5
%
1.6
1.7
0.12
107
579
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
107
480
2.33
14.11
3.7
3.4
ng/l
77.1
66.5
0.93
98
436
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
331
2.60
14.11
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
384
2626
1.63
13.97
2.0
1.7
mg/l
1.0
0.8
0.29
263
1878
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
192
1079
1.90
13.95
2.5
2.4
umol/l
7.3
5.3
0.42
148
884
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1213
10784
1.75
13.93
3.9
2.9
mmol/l
1.5
1.5
0.68
1150
10292
(42529406) Shigella sp [Presence] in Stool by Culture
90
376
2.49
13.89
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
88
368
2.48
13.56
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
65
233
2.87
13.56
3.1
2.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
387
2668
1.61
13.56
3.3
3.1
kg/l
1.0
1.0
0.16
38
420
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
211
1243
1.82
13.17
3.2
2.4
ng/l
25.2
267.1
1.75
99
507
(3026782) Osmolality of Urine
286
1849
1.68
12.84
3.2
2.3
mosm/kgh2o
525.8
546.2
0.73
244
1570
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
325
2178
1.63
12.67
1.3
1.3
u/ml
5.4
10.0
0.95
98
922
(3017143) Hepatitis C virus Ab [Presence] in Serum
368
2543
1.60
12.64
1.9
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1006
8618
1.54
12.62
4.9
3.7
e6/l
138.6
881.2
1.89
16
77
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
338
2295
1.62
12.47
1.4
1.3
iu/ml
15.0
21.9
1.93
77
700
(3037467) Urinalysis macro (dipstick) panel - Urine
1025
8829
1.54
12.43
4.6
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
340
2314
1.61
12.41
1.7
1.5
mmol/l
1.4
1.3
2.03
303
2064
(3023323) Follitropin [Units/volume] in Serum or Plasma
209
1256
1.78
12.16
1.4
1.3
iu/l
19.1
19.3
0.04
163
1058
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
175
1001
1.85
11.97
3.2
3.6
pmol/l
4.3
4.6
3.93
145
898
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
378
2662
1.57
11.87
2.1
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
187
1096
1.81
11.82
2.6
2.2
s
29.5
29.0
0.68
180
1055
(3032080) INR in Blood by Coagulation assay
379
2675
1.56
11.77
6.5
4.2
inr
1.0
1.0
0.10
119
1013
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
125
646
2.02
11.55
1.7
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
137
734
1.96
11.43
1.7
1.6
mg/l
3.2
3.4
0.23
102
475
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
66
262
2.59
11.36
8.8
12.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1226
11086
1.67
11.34
18.9
10.6
%
13.4
13.3
0.24
1203
10865
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
157
889
1.86
11.08
5.7
3.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
274
1815
1.63
11.05
1.4
1.4
titre
517.7
542.5
0.06
35
379
(3013139) Helicobacter pylori Ag [Presence] in Stool
142
785
1.90
10.79
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
193
1176
1.74
10.65
1.9
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
21
40
5.31
10.60
1.4
2.1
nmol/l
153.5
131.8
0.87
21
40
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
453
3387
1.49
10.55
2.3
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
65
266
2.51
10.53
3.6
8.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
460
3458
1.48
10.40
2.5
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
132
722
1.91
10.36
1.8
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
167
995
1.77
9.95
1.3
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
15
22
6.88
9.74
1.1
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
128
708
1.89
9.71
1.9
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
414
2.14
9.61
1.7
1.5
nmol/l
3.4
5.3
2.08
67
361
(3023511) Choriogonadotropin [Units/volume] in Urine
182
1132
1.69
9.29
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
754
6300
1.41
9.28
2.6
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
38
125
3.09
9.28
1.6
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
301
2.29
8.87
1.6
1.9
ug/l
3.2
4.8
0.56
53
271
(3000850) Epithelial cells [#/volume] in Urine
287
2030
1.52
8.51
2.8
2.2
e6/l
8.5
10.6
1.09
248
1763
(3003327) Ova and parasites identified in Stool by Light microscopy
103
556
1.92
8.42
1.8
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1386
13184
2.05
8.25
14.1
8.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
587
4765
1.39
8.24
2.0
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
222
1498
1.57
8.13
1.3
1.2
iu/ml
93.1
165.7
2.22
57
595
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
117
676
1.79
7.74
1.5
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
10
12
8.38
7.58
1.4
2.3
—
—
—
0
0
(3020891) Body temperature
45
184
2.49
7.38
3.9
4.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
474
3779
1.38
7.19
2.2
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
227
1583
1.51
7.12
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
88
479
1.89
7.05
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
165
1075
1.60
6.99
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
36
136
2.69
6.93
1.4
1.4
—
33.4
—
0
5
(3007461) Platelets [#/volume] in Blood
1441
14014
3.57
6.84
23.3
13.3
e9/l
273.9
268.0
3.14
1421
13734
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
291
2151
1.44
6.79
2.5
2.2
u/l
2850.7
6189.3
2.42
108
928
(3022217) INR in Platelet poor plasma by Coagulation assay
98
559
1.81
6.78
14.6
9.6
inr
1.0
1.1
—
10
106
(3009542) Hematocrit [Volume Fraction] of Blood
1305
12295
1.59
6.75
17.4
9.5
%
39.2
39.7
2.16
1087
10407
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
91
508
1.84
6.75
1.4
1.5
nmol/l
0.3
0.5
3.46
69
432
(3011397) Hemoglobin [Presence] in Urine by Test strip
361
2778
1.40
6.71
3.0
2.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
1441
14026
3.49
6.58
23.2
13.2
fl
89.7
89.5
1.26
1434
13893
(3035941) MCH [Entitic mass]
1441
14028
3.48
6.54
23.1
13.2
pg
29.8
29.9
0.18
1434
13893
(3026361) Erythrocytes [#/volume] in Blood
1441
14030
3.47
6.50
23.2
13.2
e12/l
4.4
4.5
1.64
1419
13751
(3010813) Leukocytes [#/volume] in Blood
1441
14033
3.45
6.43
23.4
13.3
e9/l
6.7
6.9
2.97
1419
13733
(3023410) Appearance of Cerebral spinal fluid
35
136
2.61
6.40
1.3
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1441
14038
3.41
6.33
23.4
13.3
g/l
131.7
133.0
4.49
1434
13901
(3051611) Lipemic interference index of Serum or Plasma
21
61
3.48
6.30
1.8
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
94
548
1.76
6.07
1.7
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
134
860
1.61
6.05
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
153
2.46
5.98
1.2
1.7
g/l
3.2
3.1
0.28
30
133
(3004716) Salmonella sp identified in Stool by Organism specific culture
164
1108
1.54
5.94
1.3
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
355
2775
1.37
5.91
2.1
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
41
179
2.33
5.89
1.6
2.1
ug/l
165.8
154.4
0.06
33
149
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
62
322
1.97
5.75
2.2
2.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
57
288
2.02
5.71
5.6
10.0
mmol/l
24.8
23.8
0.98
57
263
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
74
409
1.85
5.70
1.4
1.4
u/l
14.2
16.6
0.42
62
357
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
157
2.39
5.67
1.2
1.6
g/l
7.6
7.3
0.39
30
139
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
203
2.20
5.57
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
111
2.65
5.49
1.8
3.3
umol/l
28.0
30.5
0.30
22
101
(3032773) Endomysium IgG Ab [Titer] in Serum
36
154
2.37
5.43
1.5
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
59
308
1.95
5.41
2.9
2.7
ng/l
61.4
79.6
0.51
50
266
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
22
5.03
5.26
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
102
2.68
5.26
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
270
2.00
5.22
1.2
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
157
2.33
5.21
1.3
1.6
g/l
3.8
3.8
0.07
29
128
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
157
2.33
5.21
1.3
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
80
1314
0.59
5.18
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
75
431
1.78
5.12
1.9
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
145
986
1.52
5.11
3.8
2.6
%
32.9
32.8
0.04
121
758
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
78
456
1.75
5.03
1.2
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
96
1495
0.62
5.01
1.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
83
497
1.71
4.93
1.7
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
124
2.45
4.90
4.2
6.0
u/ml
0.4
0.3
0.07
15
66
(3020630) Protein [Mass/volume] in Serum or Plasma
69
394
1.79
4.83
1.4
2.0
g/l
65.9
68.3
2.16
60
374
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
43
210
2.08
4.76
3.1
3.7
mg/l
1.2
1.3
0.09
38
195
(3003338) MCHC [Mass/volume]
1214
11437
1.37
4.71
19.2
10.8
g/l
331.5
332.6
3.81
1202
11334
(3027273) Bicarbonate [Moles/volume] in Venous blood
46
232
2.01
4.68
3.7
2.8
mmol/l
25.3
24.9
0.40
46
223
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
29
4.16
4.63
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
555
4758
1.27
4.52
1.9
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
25
99
2.55
4.47
2.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
30
4.02
4.44
1.1
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
218
2.00
4.34
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
40
3.52
4.33
1.8
3.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
82
508
1.65
4.32
1.1
1.1
u/ml
3.3
4.6
0.29
12
96
(3023520) Reticulocytes [#/volume] in Blood
71
425
1.70
4.26
2.4
2.4
e9/l
69.7
73.8
0.41
44
296
(3028026) IgM [Mass/volume] in Serum or Plasma
95
613
1.59
4.25
1.5
1.8
g/l
1.2
1.5
2.74
88
566
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
199
2.04
4.25
1.2
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
51
278
1.86
4.18
1.1
1.3
titre
48.3
90.7
—
6
28
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
57
3.01
4.13
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
51
280
1.85
4.09
1.1
1.4
mmol/l
3.7
3.5
0.55
46
255
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
111
749
1.52
4.09
2.8
3.5
u/l
202.8
219.2
1.55
100
713
(3005719) IgG [Mass/volume] in Serum or Plasma
119
816
1.50
4.07
1.9
2.4
g/l
10.4
10.6
0.27
108
743
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
51
282
1.84
4.01
1.2
1.6
e6/l
735.0
13157.0
0.47
39
227
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
51
283
1.83
3.97
1.1
1.6
e6/l
17.2
18.5
0.04
38
214
(3011648) Oxygen content in Venous blood
15
48
3.15
3.93
1.6
2.7
%
11.0
11.6
0.21
15
48
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
271
3357
0.76
3.89
1.5
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
132
2.22
3.87
1.2
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
90
2.47
3.72
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
128
2.21
3.71
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
49
276
1.80
3.66
2.4
2.2
g/l
1.3
1.1
0.95
42
242
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
129
2.19
3.65
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
28
129
2.19
3.65
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
129
2.19
3.65
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
85
2.49
3.64
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
54
314
1.75
3.63
1.2
1.4
mg/l
403.6
400.4
0.02
49
292
(4146454)
12
35
3.45
3.62
2.1
3.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
26
3.87
3.52
1.3
1.5
—
—
—
0
0
(3036489) Thrombin time
72
457
1.61
3.50
1.9
2.4
s
19.9
20.9
1.81
57
366
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
132
2.14
3.46
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
64
2.68
3.40
3.3
3.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
91
617
1.51
3.32
2.8
2.5
mmol/l
1.2
1.2
0.35
75
521
(40768443) Skin Pathology biopsy report
59
361
1.66
3.32
1.2
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
59
361
1.66
3.32
2.1
2.9
%
167.0
161.0
0.23
54
346
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
119
851
1.43
3.32
2.5
2.3
au/ml
14.0
20.0
—
7
71
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
117
1608
0.70
3.31
1.4
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
41
226
1.84
3.31
1.7
1.4
—
2448.0
—
0
5
(3011985) Renin [Units/volume] in Plasma
24
109
2.22
3.26
1.4
1.6
mu/l
49.7
57.4
0.17
18
96
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
129
2.11
3.25
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
60
2.69
3.23
1.6
2.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
60
373
1.63
3.19
2.4
2.9
g/l
4.0
3.6
1.26
55
353
(3022689) Creatine [Moles/volume] in Urine
9
20
4.52
3.11
1.7
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
105
2.21
3.10
1.2
1.3
pmol/l
375.8
451.9
0.38
17
78
(3034770) Mitochondria Ab [Titer] in Serum
47
276
1.73
3.09
1.1
1.3
titre
—
713.0
—
0
10
(4010399)
85
578
1.50
3.08
1.4
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
16
62
2.60
3.05
2.1
1.8
mmol/l
65.4
82.9
—
10
56
(3004588) Protein electrophoresis panel - Serum or Plasma
47
278
1.71
3.02
1.3
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
21
4.31
2.99
1.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
63
2.56
2.96
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
155
1.96
2.96
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
47
280
1.70
2.95
1.1
1.1
u/ml
2.8
3.3
0.17
22
168
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
64
413
1.57
2.95
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
30
158
1.92
2.81
4.3
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
166
1.89
2.77
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
166
1.89
2.77
1.2
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
203
1.79
2.75
1.2
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
699
6365
1.19
2.74
3.4
3.0
estimate
0.0
0.0
0.80
118
1375
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
61
397
1.56
2.73
2.0
2.5
%
93.8
94.3
0.06
54
354
(3028433) Virus identified in Specimen by Culture
11
37
2.99
2.69
1.2
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
19
4.23
2.68
1.4
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
19
4.23
2.68
1.4
2.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
13
49
2.67
2.62
4.5
2.7
mg/l
77.4
31.6
—
6
36
(3021601) Nitrite [Presence] in Urine by Test strip
698
6371
1.18
2.62
4.9
4.1
estimate
0.0
0.0
0.50
125
1421
(3009261) Glucose [Presence] in Urine by Test strip
702
6423
1.18
2.53
3.4
3.0
estimate
0.0
0.0
0.78
121
1390
(3049717) Cytology report of Urine Cyto stain
24
123
1.97
2.46
2.3
1.8
—
—
—
0
0
(3000492) Spirometry study
146
1140
1.31
2.42
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
34
2.95
2.41
3.0
3.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
12
5.02
2.40
1.8
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
27
3.35
2.39
1.1
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
101
751
1.37
2.32
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
349
1.54
2.30
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
23
3.49
2.27
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
23
3.49
2.27
1.1
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
110
833
1.35
2.26
3.4
2.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
29
490
0.58
2.22
1.6
1.7
mmol/l
7.6
7.4
0.12
18
297
(40767503) Oxygen content in Capillary blood by calculation
24
130
1.86
2.13
3.8
1.8
%
15.6
16.9
0.84
12
61
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
95
2.01
2.11
1.2
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
170
2072
0.80
2.08
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
9
31
2.91
2.07
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
27
154
1.77
2.05
5.5
2.1
mmol/l
3.2
2.1
0.34
16
82
(3019977) pH of Arterial blood
8
26
3.09
2.01
1.4
5.0
—
7.4
—
0
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
90
2.01
2.01
1.2
2.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
9
32
2.82
2.00
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
33
201
1.66
2.00
5.0
9.3
%
1.6
1.7
0.06
33
184
(3008898) HLA-B27 [Presence]
101
771
1.33
1.99
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
126
1583
0.78
1.99
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
129
1020
1.29
1.98
1.3
1.3
u/ml
175.3
210.3
0.35
123
950
(3025159) Blasts/100 leukocytes in Blood
97
737
1.34
1.98
4.1
4.3
%
0.0
0.1
1.03
23
134
(3021901) Oxygen saturation in Capillary blood
18
91
1.99
1.95
3.1
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
27
2.97
1.93
1.9
4.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
45
2.46
1.93
1.4
2.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
92
1.97
1.90
3.3
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
33
204
1.63
1.90
5.1
9.2
%
0.9
0.9
0.42
33
188
(3030313) Adrenal Ab [Titer] in Serum
8
28
2.87
1.86
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
334
1.48
1.86
1.2
1.2
u/ml
243.1
236.9
0.06
27
217
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
410
1.43
1.83
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
30
183
1.65
1.82
1.7
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
31
191
1.64
1.82
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
215
1.60
1.80
4.1
2.9
mg/l
18.7
23.9
0.27
15
132
(3028679) Herpes simplex virus Ab [Presence] in Serum
23
131
1.77
1.78
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
240
2776
0.84
1.75
1.6
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
13
3.86
1.71
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
264
2292
1.19
1.71
2.2
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
48
0.00
1.70
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
167
1390
1.23
1.69
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
97
758
1.30
1.66
4.0
4.3
%
0.0
0.1
3.10
24
153
(3041806) Other cells [#/volume] in Blood by Manual count
32
204
1.58
1.66
1.5
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
17
90
1.90
1.65
2.4
5.7
mmol/l
6.6
6.0
0.16
12
68
(3050129) First trimester maternal screen panel - Serum or Plasma
187
2199
0.83
1.63
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
86
663
1.32
1.63
2.7
3.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
130
1058
1.25
1.62
1.4
1.3
miu/ml
203.2
243.5
0.75
61
546
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
26
2.70
1.58
2.1
3.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
26
2.70
1.58
1.6
1.3
u/l
8.6
12.5
—
7
26
(3004616) Nuclear Ab [Presence] in Serum
22
129
1.72
1.57
1.2
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
12
57
2.11
1.55
1.3
1.2
%
111.7
111.9
0.01
12
47
(3000093) Morphology [Interpretation] in Blood Narrative
12
57
2.11
1.55
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
15
3.34
1.52
1.4
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
3.1
1.3
—
—
—
0
0
(44813793)
21
123
1.72
1.51
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
58
427
1.37
1.50
2.0
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
58
2.08
1.49
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
87
1.85
1.46
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
291
0.58
1.45
1.8
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
46
328
1.42
1.44
1.2
1.5
—
7.2
—
0
10
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
16
3.13
1.44
2.0
10.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
22
2.73
1.43
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
313
1.42
1.40
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
40
2.26
1.40
2.9
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
29
2.42
1.39
3.1
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
382
1.37
1.38
1.7
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
61
1.98
1.33
1.3
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
40
0.00
1.32
0.0
2.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
98
1.74
1.31
1.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
662
6225
1.12
1.31
4.0
4.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
97
788
1.25
1.27
4.0
4.3
%
0.3
0.9
2.26
23
166
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
36
2.23
1.24
1.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
347
1.37
1.24
1.6
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
45
2.01
1.23
1.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
10
49
2.05
1.22
4.0
2.2
—
3.1
—
0
7
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
49
2.05
1.22
1.2
1.1
pmol/l
11.6
13.1
—
5
42
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
140
1.58
1.20
2.3
2.7
ug/min
30.5
102.6
0.83
14
96
(3003888) Timothy IgE Ab [Units/volume] in Serum
60
463
1.31
1.19
1.2
1.1
u/ml
2.9
6.8
2.65
33
253
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
129
0.46
1.16
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1222
11936
1.15
1.16
4.6
4.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
526
4911
1.11
1.16
1.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
126
1.60
1.14
2.1
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
142
1.56
1.14
1.0
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
57
441
1.30
1.12
1.5
2.0
u/l
38.3
38.0
0.04
49
411
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
30
2.34
1.12
3.1
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
51
1.97
1.11
1.7
2.0
mmol/l
3.5
3.9
—
10
51
(3035285) Chloride [Moles/volume] in Venous blood
10
51
1.97
1.11
1.7
2.0
mmol/l
102.6
105.9
—
10
51
(3017732) Neutrophils [#/volume] in Blood
101
840
1.22
1.09
2.0
2.0
e9/l
3.8
4.2
0.92
72
730
(3017569) Oxygen content in Arterial blood
5
21
2.39
1.09
2.4
5.6
—
—
—
0
0
(4306422)
34
244
1.40
1.08
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
304
1.36
1.08
2.0
3.0
g/l
0.2
0.3
0.47
17
127
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
558
5242
1.10
1.08
1.9
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
89
1.69
1.07
1.9
1.5
mg/l
39.4
19.6
—
5
32
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
13
74
1.76
1.07
1.3
1.5
nmol/l
2.1
1.5
0.91
13
66
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
246
1.39
1.04
1.3
1.3
u/ml
3.2
3.8
0.10
12
82
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
55
429
1.29
1.04
1.8
2.1
iu/l
2.3
4.7
3.61
20
186
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
22
2.28
1.03
2.6
2.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
55
430
1.29
1.02
1.1
1.1
u/ml
1.0
1.1
0.07
27
181
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
47
1.92
1.02
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
48
1.88
1.00
1.8
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
248
1.38
1.00
1.4
1.3
u/ml
9.1
5.4
0.34
14
96
(3015183) Erythrocyte sedimentation rate
5
110
0.45
1.00
1.0
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
17
107
1.60
0.99
7.8
15.1
mmol/l
11.4
11.4
0.03
17
93
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
257
1.37
0.99
1.0
1.1
—
—
—
0
0
(4034850)
41
309
1.34
0.99
7.0
6.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
266
1.36
0.98
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
61
1.81
0.98
2.0
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
23
2.18
0.98
1.2
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
23
2.18
0.98
6.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
63
505
1.26
0.97
1.2
1.1
u/ml
0.5
1.6
1.52
28
202
(3018572) Chloride [Moles/volume] in Blood
17
108
1.58
0.96
7.8
15.0
mmol/l
104.9
105.2
0.09
17
94
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
50
1.80
0.96
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
186
0.59
0.96
1.5
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
33
443
0.74
0.94
1.6
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
89
744
1.21
0.94
3.3
4.0
%
0.1
0.6
3.36
15
132
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
55
438
1.27
0.91
1.2
1.1
u/ml
0.5
2.0
—
10
105
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
86
1.63
0.91
1.1
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
176
1.43
0.91
1.2
1.8
g/l
0.7
0.6
0.25
17
129
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
72
1.67
0.85
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
72
1.67
0.85
1.2
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
162
1.43
0.84
1.3
1.9
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
80
671
1.20
0.84
2.2
2.3
umol/l
4.0
4.6
0.90
56
503
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
45
1.78
0.84
1.0
1.1
%
87.6
91.9
—
8
45
(3037756) Immunofixation for Serum or Plasma
10
57
1.76
0.83
1.5
1.6
—
—
—
0
0
(4062490)
18
121
1.49
0.83
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
302
1.30
0.81
1.4
1.3
u/ml
107.4
102.9
0.18
13
60
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
89
1.58
0.81
1.1
1.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
89
1.58
0.81
1.4
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
24
0.00
0.79
0.0
1.2
—
82.7
—
0
17
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
58
703
0.82
0.78
2.2
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
100
1153
0.86
0.77
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
34
1.77
0.76
1.3
1.2
—
19.0
—
0
7
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
59
1.70
0.76
1.2
1.2
u/l
181.9
415.0
—
10
52
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
83
1.57
0.75
2.2
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
7
39
1.80
0.72
1.9
1.5
—
6.6
—
0
5
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
7
40
1.75
0.71
1.0
1.1
%
115.7
105.0
—
7
35
(3019897) Erythrocyte distribution width [Ratio] by Automated count
22
298
0.73
0.71
1.5
1.8
%
13.2
13.1
0.20
22
298
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
93
1.51
0.69
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
93
1.51
0.69
1.4
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
114
1289
0.87
0.69
4.0
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
110
1.46
0.68
2.2
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
69
1.60
0.68
1.0
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
662
1.17
0.65
3.5
2.0
ml/min/173m2
85.6
85.7
0.00
42
244
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
62
1.62
0.65
1.0
1.1
iu/ml
143.3
151.4
—
10
62
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
120
1.42
0.64
1.2
1.4
g/l
6.0
6.2
—
10
79
(3042631) Mycobacterium sp identified in Specimen
8
49
1.64
0.62
2.1
2.8
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
8
50
1.60
0.61
1.1
1.1
—
—
—
0
0
(4268621)
22
165
1.34
0.60
2.8
2.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
186
0.70
0.59
1.3
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
71
817
0.86
0.57
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
87
0.57
0.56
1.0
2.5
e6/l
596.8
512.9
—
5
69
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
90
1.45
0.55
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
2.7
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
332
3145
1.07
0.52
4.2
3.7
—
—
—
0
0
(44790048)
6
99
0.60
0.52
1.0
1.3
—
—
—
0
0
(44790047)
6
99
0.60
0.52
1.0
1.3
—
—
—
0
0
(44790049)
6
99
0.60
0.52
1.0
1.3
—
—
—
0
0
(44806118)
6
99
0.60
0.52
1.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
224
1.25
0.51
2.0
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
67
1.50
0.49
4.8
8.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
110
1.37
0.49
1.3
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
41
346
1.19
0.47
1.1
1.1
u/ml
2.1
5.3
1.59
15
135
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
111
1.36
0.46
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
165
0.73
0.46
1.3
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
120
1.34
0.46
1.3
1.4
g/l
2.9
2.8
0.14
11
78
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
120
1.34
0.46
1.3
1.4
g/l
0.3
0.4
—
10
79
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
85
0.59
0.45
1.0
2.5
e9/l
0.2
0.2
—
5
69
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
52
450
1.16
0.45
1.5
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
103
1.36
0.45
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
86
1.40
0.44
2.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
31
1.61
0.43
1.6
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
31
1.61
0.43
1.4
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
31
1.61
0.43
1.4
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
87
1.38
0.42
2.4
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
32
1.56
0.42
1.8
2.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
16
0.00
0.41
0.0
2.1
—
1.1
—
0
16
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
222
1.22
0.41
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
114
1.32
0.40
1.1
1.1
u/l
1.2
1.1
—
5
40
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
2.4
—
3.2
—
0
17
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
60
1.34
0.40
3.0
2.7
u/ml
349.9
621.8
—
8
60
(3022621) pH of Urine by Test strip
72
802
0.89
0.40
2.6
2.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
115
1.31
0.39
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
104
953
1.10
0.39
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
151
1.26
0.38
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
36
1.39
0.38
1.8
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
530
5460
0.95
0.37
1.8
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(4094501)
17
134
1.27
0.37
1.1
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
28
332
0.84
0.36
1.5
1.6
mmol/l
7.0
6.6
0.34
21
231
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
71
1.27
0.36
1.3
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
157
0.76
0.36
3.9
3.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
77
0.65
0.35
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
82
899
0.91
0.35
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
19
153
1.25
0.35
4.7
2.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
82
1.34
0.34
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
45
1.33
0.33
1.2
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
36
312
1.16
0.33
1.1
1.0
u/ml
0.0
0.2
—
9
66
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
30
349
0.86
0.32
1.7
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
47
1.28
0.32
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
120
1282
0.93
0.30
1.4
1.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
151
0.79
0.28
1.0
1.0
u/ml
0.2
3.8
—
5
47
(3035933) Granulocytes/100 leukocytes in Blood
8
63
1.27
0.27
1.0
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
113
1.24
0.26
1.1
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
74
0.67
0.26
6.6
3.0
u/ml
16.4
63.4
—
5
74
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
73
1.23
0.25
1.9
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
24
207
1.16
0.25
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
455
4440
1.04
0.24
1.5
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
9
77
1.17
0.24
1.0
1.2
—
3.7
—
0
6
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
161
1.18
0.24
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
146
1389
1.06
0.24
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
237
1.14
0.23
2.6
3.5
e9/l
4.4
4.0
0.41
27
237
(3038026) Centromere Ab [Units/volume] in Serum
10
79
1.27
0.22
1.0
1.2
—
62.6
—
0
9
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
25
219
1.14
0.22
2.7
3.1
ug/l
0.9
1.5
2.12
19
200
(3045414) Leukocytes [Presence] in Urine
59
545
1.09
0.22
2.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
41
1.22
0.22
1.6
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.6
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
180
1874
0.95
0.22
1.5
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
210
1.15
0.21
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
47
430
1.10
0.21
2.1
3.8
ug/l
2.0
19.2
0.77
30
291
(3005033) Fetal Nuchal fold Thickness US
145
1385
1.05
0.21
1.5
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
2.7
—
433.1
—
0
11
(3011325) HIV 1+2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
10.4
—
0.4
—
0
10
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
7.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
239
1.13
0.21
2.7
3.7
%
57.3
56.3
0.15
27
239
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
105
0.76
0.21
1.0
1.1
miu/ml
1324.6
1420.3
—
8
105
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
43
1.16
0.21
3.8
5.6
—
78.1
—
0
8
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
145
1.17
0.20
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
345
0.90
0.20
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
108
1.21
0.20
1.2
1.2
u/ml
0.0
0.5
—
6
27
(3043238) Trisomy 21 risk [Likelihood] in Fetus
149
1428
1.05
0.20
1.5
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
146
1.17
0.19
1.6
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.4
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
41
377
1.09
0.18
1.1
1.1
u/ml
1.0
4.6
2.70
15
135
(3023419) Bacteria identified in Sputum by Culture
7
60
1.17
0.17
2.1
3.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
66
0.76
0.17
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
129
1.16
0.17
1.6
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
68
0.73
0.17
1.6
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
68
1.18
0.16
1.3
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
70
1.14
0.16
3.3
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
418
1.08
0.16
1.1
1.2
—
—
—
0
0
(4211845)
9
79
1.14
0.15
3.1
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
178
1.13
0.15
2.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
460
4673
0.98
0.14
2.2
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
131
1.15
0.14
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
228
1.10
0.13
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
180
1.11
0.13
1.9
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
40
427
0.93
0.13
1.8
1.6
iu/ml
0.0
0.2
—
10
78
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
252
0.91
0.12
1.2
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
433
1.06
0.12
2.1
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
495
5015
0.98
0.12
3.4
2.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
241
0.91
0.12
1.6
1.5
mmol/l
11.6
10.2
—
7
21
(3029937) Albumin [Presence] in Urine by Test strip
335
3407
0.98
0.12
3.6
3.2
estimate
0.0
0.0
1.08
126
1395
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
95
1.16
0.11
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
386
3912
0.98
0.10
3.1
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
116
1.12
0.09
2.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
32
339
0.94
0.08
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
56
1.07
0.08
1.3
1.1
—
—
—
0
0
(4027681)
15
136
1.10
0.08
1.3
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
65
0.77
0.08
1.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
66
1.06
0.08
1.1
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
81
786
1.03
0.08
1.2
1.3
ug/l
3.6
3.5
0.12
76
748
(40768793) Breast Pathology biopsy report
29
307
0.94
0.08
1.1
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
27
254
1.06
0.07
1.1
1.3
—
1.3
—
0
23
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
82
0.85
0.07
1.3
1.3
—
64.0
—
0
13
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
85
0.82
0.07
1.6
1.5
g/l
1.0
0.9
—
7
85
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
86
1.05
0.07
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
174
1715
1.02
0.06
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
129
1.09
0.05
2.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
47
455
1.03
0.05
3.6
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
293
0.95
0.05
2.5
2.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
110
0.91
0.05
1.1
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
14
130
1.08
0.04
1.7
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
160
1.06
0.04
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
173
1712
1.01
0.03
1.5
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
359
1.03
0.03
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
37
359
1.03
0.03
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
161
1.06
0.03
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
30
290
1.04
0.03
2.3
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
12
112
1.07
0.03
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
173
1718
1.01
0.02
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
133
1.05
0.01
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
173
1720
1.01
0.01
1.5
1.4
—
—
—
0
0
(4035726)
66
653
1.01
0.01
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
107
1.03
0.00
1.7
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
117
1.03
0.00
1.8
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
125
1.04
0.00
1.1
1.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
9
0.00
0.00
0.0
2.1
—
150.6
—
0
9
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
52
0.96
0.00
3.6
1.5
—
—
—
0
0
(4281824)
9
93
0.97
0.00
1.3
1.1
—
—
—
0
0
(4024509)
9
99
0.91
0.00
2.8
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.3
—
2.8
—
0
6
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
10.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
17.2
—
0
8
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
62
0.97
0.00
7.5
2.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_BULIMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_BULIMIA | 3.263 [2.74, 3.88] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.37 |
During the follow-up period (1.1.1998 — 31.12.2019), 213 out of 7946 females with F5_BULIMIA died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have F5_BULIMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.233% | No data |
| 5 | 1.831% | No data |
| 10 | 4.927% | No data |
| 15 | 9.511% | No data |
| 20 | 15.712% | No data |
Relationships between endpoints
↥Index endpoint: F5_BULIMIA – Bulimia nervosa (incl. atypical)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data